$361 Million is the total value of SABBY MANAGEMENT, LLC's 71 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 68.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | SPDR S&P 500 ETFput | $177,023,000 | +497.7% | 5,500 | +451.1% | 49.08% | +207.5% | |
Buy | SPDR S&P 500 ETFcall | $52,013,000 | +247.1% | 1,616 | +220.0% | 14.42% | +78.6% | |
New | SPDR GOLD TRput | $24,836,000 | – | 1,738 | +100.0% | 6.88% | – | |
Sell | ISHARES TRcall | $21,504,000 | -9.1% | 1,298 | -17.0% | 5.96% | -53.2% | |
Sell | IONIS PHARMACEUTICALS INCcall | $17,887,000 | -1.7% | 2,961 | -2.5% | 4.96% | -49.4% | |
Sell | SPDR GOLD TRcall | $15,290,000 | -28.7% | 1,070 | -55.9% | 4.24% | -63.3% | |
GLD | New | SPDR GOLD TR | $5,366,000 | – | 37,550 | +100.0% | 1.49% | – |
Sell | SPDR S&P BIOTECHput | $4,756,000 | +23.0% | 500 | -1.4% | 1.32% | -36.7% | |
Sell | AMARIN CORP PLCput | $4,387,000 | +26.0% | 2,046 | -10.9% | 1.22% | -35.2% | |
Buy | AMARIN CORP PLCcall | $4,365,000 | +50.3% | 2,036 | +6.3% | 1.21% | -22.7% | |
New | SPDR S&P BIOTECHcall | $3,662,000 | – | 385 | +100.0% | 1.02% | – | |
ONTX | Buy | ONCONOVA THERAPEUTICS INC | $3,348,000 | +390.9% | 8,741,243 | +988.8% | 0.93% | +152.2% |
ODT | Sell | ODONATE THERAPEUTICS INC | $1,747,000 | -27.7% | 53,839 | -42.0% | 0.48% | -62.8% |
New | ARQULE INC COMcall | $1,541,000 | – | 772 | +100.0% | 0.43% | – | |
New | NABRIVA THERAPEUTICS PLC | $1,367,000 | – | 1,035,667 | +100.0% | 0.38% | – | |
New | SORRENTO THERAPEUTICS INCput | $1,173,000 | – | 3,471 | +100.0% | 0.32% | – | |
GNCA | Buy | GENOCEA BIOSCIENCES INC | $1,114,000 | -19.5% | 538,359 | +12.8% | 0.31% | -58.6% |
Sell | OBALON THERAPEUTICS INC | $1,084,000 | -18.5% | 570,418 | -16.8% | 0.30% | -58.0% | |
BPTH | New | BIO PATH HOLDINGS INC | $986,000 | – | 123,346 | +100.0% | 0.27% | – |
Sell | BRAINSTORM CELLput | $894,000 | -12.0% | 2,088 | -19.9% | 0.25% | -54.7% | |
PAVMZ | Sell | PAVMED INC*w | $836,000 | -11.9% | 2,152,719 | -27.4% | 0.23% | -54.6% |
New | BIOGEN INCcall | $831,000 | – | 28 | +100.0% | 0.23% | – | |
Buy | ORAMED PHARMACEUTICALS INCput | $804,000 | +1769.8% | 1,562 | +1057.0% | 0.22% | +869.6% | |
Sell | MICROBOT MED INC | $773,000 | +74.9% | 76,000 | -8.8% | 0.21% | -10.1% | |
ATNM | Sell | ACTINIUM PHARMACEUTICALS INC | $713,000 | -64.8% | 3,275,718 | -62.8% | 0.20% | -81.8% |
Buy | PLURISTEM THERAPEUTICS INCput | $708,000 | +956.7% | 1,796 | +903.4% | 0.20% | +444.4% | |
Buy | AVEO PHARMACEUTICALS INCput | $673,000 | +35.1% | 10,851 | +84.1% | 0.19% | -30.2% | |
Buy | TOP SHIPS INC | $639,000 | +11.7% | 799,212 | +291.3% | 0.18% | -42.5% | |
BNTC | New | BENITEC BIOPHARMA LTDadr | $603,000 | – | 118,285 | +100.0% | 0.17% | – |
Sell | AURINIA PHARMACEUTICALScall | $590,000 | -34.2% | 291 | -82.6% | 0.16% | -66.0% | |
PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $576,000 | +10.8% | 94,351 | -24.4% | 0.16% | -42.9% |
AMRN | Sell | AMARIN CORP PLCadr | $575,000 | +22.3% | 26,810 | -13.5% | 0.16% | -37.2% |
PSTV | Buy | PLUS THERAPEUTICS INC | $562,000 | +44.5% | 234,124 | +106.1% | 0.16% | -25.7% |
INNT | Sell | INNOVATE BIOPHARMACEUTICLS INC | $525,000 | -60.7% | 941,586 | -24.6% | 0.15% | -79.7% |
Buy | DIFFUSION PHARMACEUTICALS INC | $500,000 | -42.2% | 1,085,446 | +132.0% | 0.14% | -70.2% | |
GHSI | New | GUARDION HEALTH SCIENCES INC | $439,000 | – | 1,993,929 | +100.0% | 0.12% | – |
PULM | Sell | PULMATRIX INC | $384,000 | -55.7% | 446,749 | -57.8% | 0.11% | -77.3% |
XBIO | Sell | XENETIC BIOSCIENCES INC | $382,000 | -21.1% | 265,498 | -34.4% | 0.11% | -59.4% |
SNCA | New | SENECA BIOPHARMA INC | $378,000 | – | 381,487 | +100.0% | 0.10% | – |
SYN | Sell | SYNTHETIC BIOLOGICS INC | $348,000 | -8.2% | 687,304 | -17.7% | 0.10% | -52.9% |
XBIOW | Sell | XENETIC BIOSCIENCES INC*w | $297,000 | +15.1% | 216,789 | -18.7% | 0.08% | -41.0% |
AIM | Buy | AIM IMMUNOTECH INC | $288,000 | +104.3% | 528,811 | +185.6% | 0.08% | +5.3% |
EARS | Buy | AURIS MED HLDG LTD | $278,000 | -39.7% | 171,883 | +2.6% | 0.08% | -69.0% |
RWLK | Buy | REWALK ROBOTICS LTD | $273,000 | -22.4% | 126,280 | +9.8% | 0.08% | -60.0% |
NURO | New | NEUROMETRIX INC | $275,000 | – | 63,880 | +100.0% | 0.08% | – |
NSPR | Sell | INSPIREMD INC | $270,000 | -33.8% | 250,000 | -20.3% | 0.08% | -65.9% |
OTLK | New | OUTLOOK THERAPEUTICS INC | $229,000 | – | 388,936 | +100.0% | 0.06% | – |
PSTI | Buy | PLURISTEM THERAPEUTICS INC | $222,000 | +59.7% | 56,442 | +51.8% | 0.06% | -17.3% |
New | AVEO PHARMACEUTICALS INCcall | $225,000 | – | 3,625 | +100.0% | 0.06% | – | |
ABEO | New | ABEONA THERAPEUTICS INC | $197,000 | – | 60,361 | +100.0% | 0.06% | – |
OGEN | Sell | ORAGENICS INC | $184,000 | -44.9% | 351,045 | -43.3% | 0.05% | -71.7% |
BLIN | BRIDGELINE DIGITAL INC COM | $169,000 | -19.5% | 110,000 | 0.0% | 0.05% | -58.4% | |
VIKING THERAPEUTICS INCcall | $160,000 | +15.9% | 200 | 0.0% | 0.04% | -40.5% | ||
DMPI | Buy | DELMAR PHARMACEUTICALS INC | $153,000 | -70.9% | 1,226,022 | +28.9% | 0.04% | -85.2% |
GNPX | Sell | GENPREX INC | $142,000 | -69.3% | 443,441 | -23.2% | 0.04% | -84.3% |
LPCN | New | LIPOCINE INC | $142,000 | – | 367,693 | +100.0% | 0.04% | – |
CLSN | Sell | CELSION CORP | $117,000 | -51.2% | 68,560 | -56.1% | 0.03% | -75.2% |
SHIPZ | Sell | SEANERGY MARITIME HOLDINGS CORP*w | $100,000 | -27.5% | 907,999 | -1.0% | 0.03% | -62.2% |
VBLT | Sell | VASCULAR BIOGENICS LTD | $96,000 | -40.7% | 80,295 | -32.9% | 0.03% | -69.0% |
New | AKERS BIOSCIENCES INC | $93,000 | – | 29,100 | +100.0% | 0.03% | – | |
SRNE | New | SORRENTO THERAPEUTICS INC | $92,000 | – | 27,178 | +100.0% | 0.03% | – |
AEZS | Buy | AETERNA ZENTARIS INC | $93,000 | +25.7% | 101,976 | +41.5% | 0.03% | -35.0% |
MDGSW | MEDIGUS LTD*w | $93,000 | -7.9% | 1,008,444 | 0.0% | 0.03% | -51.9% | |
ALT | Buy | ALTIMMUNE INC COM | $85,000 | +4.9% | 44,855 | +7.4% | 0.02% | -45.5% |
SPHS | New | SOPHIRIS BIO INC | $68,000 | – | 42,378 | +100.0% | 0.02% | – |
New | TENAX THERAPEUTICS INC | $61,000 | – | 43,164 | +100.0% | 0.02% | – | |
CELSION CORPput | $31,000 | +10.7% | 184 | 0.0% | 0.01% | -40.0% | ||
RBZHF | New | REEBONZ HLDG LTD | $29,000 | – | 25,000 | +100.0% | 0.01% | – |
SNES | SENESTECH INC | $27,000 | -44.9% | 48,294 | 0.0% | 0.01% | -73.1% | |
SHIP | Sell | SEANERGY MARITIME HOLDINGS CORP | $27,000 | -95.4% | 49,999 | -95.9% | 0.01% | -97.8% |
Sell | ADAMIS PHARMACEUTICALS CORPput | $8,000 | 0.0% | 111 | -2.6% | 0.00% | -50.0% | |
BNTCW | Exit | BENITEC BIOPHARMA LTD*w | $0 | – | -51,449 | -100.0% | -0.00% | – |
Exit | TITAN PHARMACEUTICALS INCput | $0 | – | -106 | -100.0% | -0.00% | – | |
ONTXW | Exit | ONCONOVA THERAPEUTICS INC*w | $0 | – | -631,812 | -100.0% | -0.01% | – |
TTNP | Exit | TITAN PHARMACEUTICALS INC | $0 | – | -83,218 | -100.0% | -0.01% | – |
Exit | ALTIMMUNE INC COMput | $0 | – | -134 | -100.0% | -0.01% | – | |
Exit | CELSION CORPcall | $0 | – | -260 | -100.0% | -0.02% | – | |
Exit | SESEN BIO INCput | $0 | – | -365 | -100.0% | -0.02% | – | |
BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -42,007 | -100.0% | -0.02% | – |
TMDI | Exit | TITAN MEDICAL INC | $0 | – | -41,085 | -100.0% | -0.02% | – |
VISL | Exit | VISLINK TECHNOLOGIES INC | $0 | – | -115,314 | -100.0% | -0.03% | – |
EYEN | Exit | EYENOVIA INC | $0 | – | -17,900 | -100.0% | -0.04% | – |
ADMP | Exit | ADAMIS PHARMACEUTICALS CORP | $0 | – | -183,359 | -100.0% | -0.07% | – |
Exit | CEL SCI CORPcall | $0 | – | -187 | -100.0% | -0.09% | – | |
ABILF | Exit | ABILITY INC | $0 | – | -312,642 | -100.0% | -0.10% | – |
RKDA | Exit | ARCADIA BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.13% | – |
CYTR | Exit | CYTRX CORP | $0 | – | -729,450 | -100.0% | -0.13% | – |
OPTT | Exit | OCEAN PWR TECHNOLOGIES INC | $0 | – | -150,000 | -100.0% | -0.14% | – |
Exit | INPIXON | $0 | – | -2,360,220 | -100.0% | -0.15% | – | |
HEPA | Exit | HEPION PHARMACEUTICALS INC | $0 | – | -115,000 | -100.0% | -0.15% | – |
NURO | Exit | NEUROMETRIX INC | $0 | – | -934,212 | -100.0% | -0.16% | – |
Exit | KADMON HLDGS INCput | $0 | – | -114 | -100.0% | -0.17% | – | |
CUR | Exit | NEURALSTEM INC | $0 | – | -204,823 | -100.0% | -0.18% | – |
Exit | ORAMED PHARMACEUTICALS INCcall | $0 | – | -1,120 | -100.0% | -0.19% | – | |
ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -549,900 | -100.0% | -0.20% | – |
AVCO | Exit | AVALON GLOBOCARE CORP | $0 | – | -197,119 | -100.0% | -0.20% | – |
ADXS | Exit | ADVAXIS INC | $0 | – | -1,521,982 | -100.0% | -0.22% | – |
VBIV | Exit | VBI VACCINES INC | $0 | – | -876,157 | -100.0% | -0.22% | – |
Exit | GENOCEA BIOSCIENCES INCcall | $0 | – | -1,481 | -100.0% | -0.23% | – | |
VXRT | Exit | VAXART INC | $0 | – | -1,197,710 | -100.0% | -0.23% | – |
SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -491,237 | -100.0% | -0.24% | – |
SOLO | Exit | ELECTRAMECCANICA VEHS CORP | $0 | – | -288,408 | -100.0% | -0.32% | – |
ORMP | Exit | ORAMED PHARMACEUTICALS INC | $0 | – | -185,800 | -100.0% | -0.32% | – |
CTXR | Exit | CITIUS PHARMACEUTICALS INC | $0 | – | -845,432 | -100.0% | -0.34% | – |
Exit | CEL SCI CORPput | $0 | – | -855 | -100.0% | -0.41% | – | |
BHVN | Exit | BIOHAVEN PHARMACEUTICAL HLDG CO LTD | $0 | – | -19,850 | -100.0% | -0.45% | – |
BNTC | Exit | BENITEC BIOPHARMA LTDadr | $0 | – | -1,365,615 | -100.0% | -0.52% | – |
Exit | CORMEDIX INCput | $0 | – | -1,936 | -100.0% | -0.67% | – | |
ARCT | Exit | ARCTURUS THERAPEUTICS HLDG INC | $0 | – | -124,843 | -100.0% | -0.69% | – |
CJJD | Exit | CHINA JO-JO DRUGSTORES INC | $0 | – | -1,325,299 | -100.0% | -0.86% | – |
CRMD | Exit | CORMEDIX INC | $0 | – | -249,198 | -100.0% | -0.86% | – |
Exit | BIOHAVEN PHARMACEUTICAL HLDG CO LTDput | $0 | – | -412 | -100.0% | -0.93% | – | |
TEUM | Exit | PARETEUM CORP | $0 | – | -2,248,578 | -100.0% | -1.56% | – |
Exit | ISHARES TRput | $0 | – | -1,578 | -100.0% | -12.87% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
ISHARES TR | 35 | Q3 2023 | 52.2% |
SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
BIOGEN INC | 24 | Q1 2021 | 26.2% |
SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
BIOGEN INC | 23 | Q1 2021 | 13.7% |
SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.